Company intelligence / Profile preview
Eliava Biopreparations
Tbilisi, Tbilisi, Georgiapha.ge ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Eliava Biopreparations produces clinically established commercial bacteriophage preparations used for human health, veterinary, and environmental applications; their products are distributed in over 60 countries, with customized solutions showing clinical benefits for antibiotic-resistant and chronic infections[1][2][6].
- Therapeutic areas
- Infectious Diseases
- Modalities
- Live biotherapeutic product therapyMicrobial therapyBiologic
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Eliava Institute of Bacteriophages, Microbiology, and VirologyEliava Consortium membersVarious international academic and industry collaborations (EU Horizon2020, Swiss National Science Foundation)[1][6]
Beyond the preview
Go deeper on Eliava Biopreparations.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eliava Biopreparations.